{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HPLC-MS/MS", "cytotoxicity", "herbal extract", "malignant melanoma", "reactive oxygen species"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27843296", "DateCompleted": {"Year": "2017", "Month": "03", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "11", "Day": "01"}], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2016"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells.", "Pagination": {"StartPage": "3563", "EndPage": "3572", "MedlinePgn": "3563-3572"}, "Abstract": {"AbstractText": ["Malignant melanoma (MM) is the most dangerous type of skin cancer, killing more than 1,100 people each year in Canada. Prognosis for late stage and recurrent MM is extremely poor due to insensitivity to chemotherapy drugs, and thus many patients seek complementary and alternative medicines. In this study, we examined four commonly used anticancer herbs in traditional Chinese medicine, <i>Hedyotis diffusa</i>, <i>Scutellaria barbata</i>, <i>Lobelia chinensis</i>, and <i>Solanum nigrum</i>, for their in vitro antitumor effects toward human MM cell line A-375. The crude water extract of <i>S. nigrum</i> (1 g of dry herb in 100 mL water) and its 2-fold dilution caused 52.8%\u00b113.0% and 17.3%\u00b12.7% cytotoxicity in A-375 cells, respectively (<i>P</i><0.01). The crude water extract of <i>H. diffusa</i> caused 11.1%\u00b112.4% cytotoxicity in A-375 cells with no statistical significance (<i>P</i>>0.05). Higher concentrated formulation might be needed for <i>H. diffusa</i> to exert its cytotoxic effect against A-375 cells. No cytotoxicity was observed in A-375 cells treated with crude water extract of <i>S. barbata</i> and <i>L. chinensis</i>. Further high performance liquid chromatography-tandem mass spectroscopy analysis of the herbal extracts implicated that <i>S. nigrum</i> and <i>H. diffusa</i> might have adopted the same bioactive components for their cytotoxic effects in spite of belonging to two different plant families. We also showed that the crude water extract of <i>S. nigrum</i> reduced intracellular reactive oxygen species generation in A-375 cells, which may lead to a cytostatic effect. Furthermore, synergistic effect was achieved when crude water extract of <i>S. nigrum</i> was coadministered with temozolomide, a chemotherapy drug for skin cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK; Department of Biomedical and Molecular Sciences, Queen's University, Cancer Biology & Genetics Division, Queen's Cancer Research Institute, Kingston, ON, Canada."}], "LastName": "Ling", "ForeName": "Binbing", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK."}], "LastName": "Michel", "ForeName": "Deborah", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK."}], "LastName": "Sakharkar", "ForeName": "Meena Kishore", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK."}], "LastName": "Yang", "ForeName": "Jian", "Initials": "J"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Alkylating"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Solvents"}, {"RegistryNumber": "059QF0KO0R", "NameOfSubstance": "Water"}, {"RegistryNumber": "7GR28W0FJI", "NameOfSubstance": "Dacarbazine"}, {"RegistryNumber": "YF1K15M17Y", "NameOfSubstance": "Temozolomide"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Alkylating"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Dacarbazine"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hedyotis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Lobelia"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Melanoma"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["chemistry"], "DescriptorName": "Scutellaria"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Solanum nigrum"}, {"QualifierName": ["chemistry"], "DescriptorName": "Solvents"}, {"QualifierName": [], "DescriptorName": "Tandem Mass Spectrometry"}, {"QualifierName": [], "DescriptorName": "Temozolomide"}, {"QualifierName": ["chemistry"], "DescriptorName": "Water"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "American Cancer Society . Cancer Facts & Figures. Atlanta: 2014."}, {"Citation": "Canadian Cancer Society . Canadian Cancer Statistics. Canada: Public Health Agency of Canada; 2015."}, {"Citation": "Helmbach H, Rossmann E, Kern MA, Schadendorf D. Drug-resistance in human melanoma. Int J Cancer. 2001;93:617\u2013622.", "ArticleIdList": ["11477569"]}, {"Citation": "HemaIswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res. 2006;40(4):239\u2013249.", "ArticleIdList": ["16557604"]}, {"Citation": "Cheng KC, Li YX, Cheng JT. The use of herbal medicine in cancer-related anorexia/cachexia treatment around the world. Curr Pharm Des. 2012;18(31):4819\u20134826.", "ArticleIdList": ["22632862"]}, {"Citation": "Yang C, Chien LY, Tai CJ. Use of complementary and alternative medicine among patients with cancer receiving outpatient chemotherapy in Taiwan. J Altern Complement Med. 2008;14(4):413\u2013416.", "ArticleIdList": ["18435601"]}, {"Citation": "Shenefelt PD. Herbal treatment for dermatologic disorders. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton: CRC Press/Taylor & Francis; 2011. pp. 383\u2013404."}, {"Citation": "Zink A, Traidl-Hoffmann C. Green tea in dermatology \u2013 myths and facts. J Dtsch Dermatol Ges. 2015;13(8):768\u2013775.", "ArticleIdList": ["26177066"]}, {"Citation": "Riondel J, Jacrot M, Picot F, Beriel H, Mouriquand C, Potier P. Therapeutic response to taxol of six human tumors xenografted into nude mice. Cancer Chemother Pharmacol. 1986;17(2):137\u2013142.", "ArticleIdList": ["2872974"]}, {"Citation": "Slichenmyer WJ, Von Hoff DD. Taxol: a new and effective anti-cancer drug. Anticancer Drugs. 1991;2(6):519\u2013530.", "ArticleIdList": ["1687206"]}, {"Citation": "Wachtel-Galor S, Benzie IFF. Herbal medicine: an introduction to its history, usage, regulation, current trends, and research needs. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton: CRC Press/Taylor & Francis; 2011. pp. 1\u201310.", "ArticleIdList": ["22593939"]}, {"Citation": "Damery S, Gratus C, Grieve R, et al. The use of herbal medicines by people with cancer: a cross-sectional survey. Br J Cancer. 2011;104(6):927\u2013933.", "ArticleIdList": ["PMC3065283", "21364591"]}, {"Citation": "Rugo H, Shtivelman E, Perez A, et al. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat. 2007;105(1):17\u201328.", "ArticleIdList": ["17111207"]}, {"Citation": "Perez AT, Arun B, Tripathy D, et al. A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat. 2010;120(1):111\u2013118.", "ArticleIdList": ["20054647"]}, {"Citation": "Saif MW, Li J, Lamb L, et al. First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer. Cancer Chemother Pharmacol. 2014;73(2):373\u2013380.", "ArticleIdList": ["PMC4123311", "24297682"]}, {"Citation": "Shao J, Gong G, Trombetta L. An evidence-based perspective of Hedyotis diffusa or Oldenlandia diffusa (spreading Hedyotis) for cancer patients. In: Cho WCS, editor. Evidence Based Anticancer Material Medica. Berlin: Springer; 2011. pp. 179\u2013192."}, {"Citation": "Ling B, Dong Q, Sun W, et al. Evaluating the anticancer activity of Hedyotis diffusa water extract against human breast cancer MCF7 cells. Open Nat Prod J. 2013;6(1):1\u20134."}, {"Citation": "Dong Q, Ling B, Gao B, Maley J, Sammynaiken R, Yang J. Hedyotis diffusa water extract diminished the cytotoxic effects of chemotherapy drugs against human breast cancer MCF7 cells. Nat Prod Commun. 2014;9:699\u2013700.", "ArticleIdList": ["25026725"]}, {"Citation": "Li C, Zhao Y, Guo Z, Zhang X, Xue X, Liang X. Effective 2D-RPLC/RPLC enrichment and separation of micro-components from Hedyotis diffusa Willd and characterization by using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal. 2014;99:35\u201344.", "ArticleIdList": ["25061712"]}, {"Citation": "Ye L, Jia Y, Ji KE, et al. Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis. Oncol Lett. 2015;10(3):1240\u20131250.", "ArticleIdList": ["PMC4533180", "26622657"]}, {"Citation": "Chen MW, Chen WR, Zhang JM, Long XY, Wang YT. Lobelia chinensis: chemical constituents and anticancer activity perspective. Chin J Nat Med. 2014;12(2):103\u2013107.", "ArticleIdList": ["24636059"]}, {"Citation": "Han SR, Lv XY, Wang YM, et al. A study on the effect of aqueous extract of Lobelia chinensis on colon precancerous lesions in rats. Afr J Tradit Complement Altern Med. 2013;10(6):422\u2013425.", "ArticleIdList": ["PMC3847375", "24311860"]}, {"Citation": "Santosa MH, Herzog R, Voelter W. Antitumor activity of the hot water extract of Lobelia chinensis. Planta Med. 1986;6:555.", "ArticleIdList": ["17345524"]}, {"Citation": "Yang S, Shen T, Zhao L, et al. Chemical constituents of Lobelia chinensis. Fitoterapia. 2014;93:168\u2013174.", "ArticleIdList": ["24444893"]}, {"Citation": "Wang CK, Lin YF, Tai CJ, et al. Integrated treatment of aqueous extract of Solanum nigrum-potentiated cisplatin- and doxorubicin-induced cytotoxicity in human hepatocellular carcinoma cells. Evid Based Complement Alternat Med. 2015;2015:675270.", "ArticleIdList": ["PMC4499398", "26221175"]}, {"Citation": "Tai CJ, Wang CK, Tai CJ, et al. Aqueous extract of Solanum nigrum leaves induces autophagy and enhances cytotoxicity of cisplatin, doxorubicin, docetaxel, and 5-fluorouracil in human colorectal carcinoma cells. Evid Based Complement Alternat Med. 2013;2013:514719.", "ArticleIdList": ["PMC3703357", "23843876"]}, {"Citation": "Lai YJ, Tai CJ, Wang CW, et al. Anti-cancer activity of solanum nigrum (AESN) through suppression of mitochondrial function and epithelial-mesenchymal transition (EMT) in breast cancer cells. Molecules. 2016;21(5) pii E553.", "ArticleIdList": ["PMC6274361", "27136519"]}, {"Citation": "Li J, Li Q, Feng T, Li K. Aqueous extract of Solanum nigrum inhibit growth of cervical carcinoma (U14) via modulating immune response of tumor bearing mice and inducing apoptosis of tumor cells. Fitoterapia. 2008;79(7\u20138):548\u2013556.", "ArticleIdList": ["18687388"]}, {"Citation": "Wang HC, Wu DH, Chang YC, Li YJ, Wang CJ. Solanum nigrum Linn. water extract inhibits metastasis in mouse melanoma cells in vitro and in vivo. J Agric Food Chem. 2010;58(22):11913\u201311923.", "ArticleIdList": ["21028816"]}, {"Citation": "Ding X, Zhu F, Yang Y, Li M. Purification, antitumor activity in vitro of steroidal glycoalkaloids from black nightshade (Solanum nigrum L.) Food Chem. 2013;141(2):1181\u20131186.", "ArticleIdList": ["23790901"]}, {"Citation": "Yang MY, Hsu LS, Peng CH, Shi YS, Wu CH, Wang CJ. Polyphenol-rich extracts from Solanum nigrum attenuated PKC alpha-mediated migration and invasion of hepatocellular carcinoma cells. J Agric Food Chem. 2010;58(9):5806\u20135814.", "ArticleIdList": ["20349911"]}, {"Citation": "Li J, Li QW, Gao DW, Han ZS, Lu WZ. Antitumor and immunomodulating effects of polysaccharides isolated from Solanum nigrum Linne. Phytother Res. 2009;23(11):1524\u20131530.", "ArticleIdList": ["19449342"]}, {"Citation": "Heo KS, Lee SJ, Ko JH, Lim K, Lim KT. Glycoprotein isolated from Solanum nigrum L. inhibits the DNA-binding activities of NF-kappaB and AP-1, and increases the production of nitric oxide in TPA-stimulated MCF-7 cells. Toxicol In Vitro. 2004;18(6):755\u2013763.", "ArticleIdList": ["15465640"]}, {"Citation": "Jeong JB, De Lumen BO, Jeong HJ. Lunasin peptide purified from Solanum nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl radical via blocking fenton reaction. Cancer Lett. 2010;293(1):58\u201364.", "ArticleIdList": ["20083341"]}, {"Citation": "Ling B, Gao B, Yang J. Evaluating the effects of tetrachloro-1,4- benzoquinone, an active metabolite of pentachlorophenol, on the growth of human breast cancer cells. J Toxicol. 2016;2016:8253726.", "ArticleIdList": ["PMC4769760", "26981120"]}, {"Citation": "Kuo YJ, Yang JS, Lu CC, Chiang SY, Lin JG, Chung JG. Ethanol extract of Hedyotis diffusa willd upregulates G0/G1 phase arrest and induces apoptosis in human leukemia cells by modulating caspase cascade signaling and altering associated genes expression was assayed by cDNA microarray. Environ Toxicol. 2015;30(10):1162\u20131177.", "ArticleIdList": ["24677778"]}, {"Citation": "Li M, Hou XF, Zhang J, Wang SC, Fu Q, He LC. Applications of HPLC/MS in the analysis of traditional Chinese medicines. J Pharm Anal. 2011;1(2):81\u201391.", "ArticleIdList": ["PMC5760786", "29403684"]}, {"Citation": "Jensen PH, Juhler RK, Nielsen NJ, et al. Potato glycoalkaloids in soil-optimising liquid chromatography-time-of-flight mass spectrometry for quantitative studies. J Chromatogr A. 2008;1182(1):65\u201371.", "ArticleIdList": ["18221744"]}, {"Citation": "Lo JA, Fisher DE. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science. 2014;346(6212):945\u2013949.", "ArticleIdList": ["PMC4701046", "25414302"]}, {"Citation": "Swalwell H, Latimer J, Haywood RM, Birch-Machin MA. Investigating the role of melanin in UVA/UVB- and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells. Free Radic Biol Med. 2012;52(3):626\u2013634.", "ArticleIdList": ["22178978"]}, {"Citation": "Kamenisch Y, Baban TS, Schuller W, et al. UVA-irradiation induces melanoma invasion via enhanced Warburg effect. J Invest Dermatol. 2016;136(9):1866\u20131875.", "ArticleIdList": ["27185340"]}, {"Citation": "Sander CS, Hamm F, Elsner P, Thiele JJ. Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol. 2003;148(5):913\u2013922.", "ArticleIdList": ["12786821"]}, {"Citation": "Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991;51(3):794\u2013798.", "ArticleIdList": ["1846317"]}, {"Citation": "Gidanian S, Mentelle M, Meyskens FL, Jr, Farmer PJ. Melanosomal damage in normal human melanocytes induced by UVB and metal uptake \u2013 a basis for the pro-oxidant state of melanoma. Photochem Photobiol. 2008;84(3):556\u2013564.", "ArticleIdList": ["PMC5746029", "18331399"]}, {"Citation": "Lin X, Zheng W, Liu J, et al. Oxidative stress in malignant melanoma enhances tumor necrosis factor-\u03b1 secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxid Redox Signal. 2013;19(12):1337\u20131355.", "ArticleIdList": ["23373752"]}, {"Citation": "Joosse A, De Vries E, van Eijck CH, Eggermont AM, Nijsten T, Coebergh JW. Reactive oxygen species and melanoma: an explanation for gender differences in survival? Pigment Cell Melanoma Res. 2010;23(3):352\u2013364.", "ArticleIdList": ["20218981"]}, {"Citation": "Finn L, Markovic SN, Joseph RW. Therapy for metastatic melanoma: the past, present, and future. BMC Med. 2012;10:23.", "ArticleIdList": ["PMC3308914", "22385436"]}, {"Citation": "Azzabi A, Hughes AN, Calvert PM, et al. Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. Br J Cancer. 2005;92(6):1006\u20131012.", "ArticleIdList": ["PMC2361941", "15756276"]}, {"Citation": "Bafaloukos D, Tsoutsos D, Kalofonos H, et al. Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group. Ann Oncol. 2005;16(6):950\u2013957.", "ArticleIdList": ["15829494"]}, {"Citation": "Middleton MR, Grob JJ, Aaronson N, et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol. 2000;18(1):158\u2013166.", "ArticleIdList": ["10623706"]}, {"Citation": "Alrwas A, Papadopoulos NE, Cain S, et al. Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-\u03b1 in patients with metastatic melanoma. Melanoma Res. 2014;24(4):342\u2013348.", "ArticleIdList": ["PMC4278368", "24743052"]}, {"Citation": "Beasley GM, Speicher P, Augustine CK, et al. A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion. Ann Surg Oncol. 2015;22(1):287\u2013294.", "ArticleIdList": ["PMC4464816", "25145500"]}, {"Citation": "Kaufmann R, Spieth K, Leiter U, et al. Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the dermatologic cooperative oncology group. J Clin Oncol. 2005;23(35):9001\u20139007.", "ArticleIdList": ["16260697"]}, {"Citation": "Sharma G, Tyagi AK, Singh RP, Chan DC, Agarwal R. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Breast Cancer Res Treat. 2004;85(1):1\u201312.", "ArticleIdList": ["15039593"]}, {"Citation": "Xu WW, Li B, Lai ET, et al. Water extract from Pleurotus pulmonarius with antioxidant activity exerts in vivo chemoprophylaxis and chemo-sensitization for liver cancer. Nutr Cancer. 2014;66(6):989\u2013998.", "ArticleIdList": ["25072857"]}, {"Citation": "Chen NC, Chyau CC, Lee YJ, Tseng HC, Chou FP. Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cells. Sci Rep. 2016;6:20417.", "ArticleIdList": ["PMC4738303", "26838546"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["27843296", "PMC5098531", "10.2147/DDDT.S119214", "dddt-10-3563"]}}], "PubmedBookArticle": []}